A clinical trial to study the effect of Kanakasava Nebulizer Solution in Patients with COPD
- Conditions
- Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
- Registration Number
- CTRI/2022/09/045966
- Lead Sponsor
- Dean Faculty of Ayurved Parul University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 73
1 Patients between age group 18 to 60 years (both years inclusive) of either gender.
2 Patients diagnosed with Mild to Moderate COPD as per GOLD Guidelines 2020.
3 Patients with symptom of Shwaskashta (Dyspnea) even while resting.
4 Willing and able to give written informed consent.
1 Pregnant or Lactating women
2 History of any chronic respiratory disease other than COPD
3 Patients with known case of Systemic Diseases like Uncontrolled Diabetes and Hypertension.
4 Severe cases of COPD as per GOLD guidelines 2020.
5 History of upper or lower respiratory tract infection, within the previous 30 days.
6 History of lung resection of more than one full lobe.
7 Have a known sensitivity to formoterol, ipratropium, salbutamol.
8 Immunocompromised status such as HIV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.